Cencora (COR)
NYSEHealth CareMedical - DistributionSnapshot 2026-11-05
NYSEHealth CareMedical - DistributionSnapshot 2026-11-05
QuarterlyIQ Insights · COR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 10.1% |
| Our one-year growth estimate | diamond | 5.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 4.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 2 industry peers · Company calendar date is not available
COR — restructuring
Dated 2026-11-04
Regulation FD Disclosure. New Reporting Structure In order to advance its growth priorities, Cencora recently completed a restructuring of its operating model intended to strengthen execution and improve visibility. As a result of this restructuring, the Company has reorganized all business components within the U.S. Healthcare Solutions and International Healthcare Solutions reportable segments. Beginning in the first quarter of fiscal 2027, the Company’s reporting structure will be comprise…
Why it matters: Cencora plans to discuss its fiscal 2027 outlook on November 4. The outlook can show if growth continues.
Watch forManagement gives fiscal 2027 adjusted EPS growth guidance of 10% or more, in line with its long-term range.
Also watch forManagement guides to fiscal 2027 adjusted EPS growth below 10%, or stops backing its long-term growth range.
Why it matters: The U.S. segment drove much of recent growth, including specialty sales. A sharp slowdown could weaken the earnings trend.
Watch forU.S. Healthcare Solutions revenue growth stays above 4.9% year over year, its fiscal 2026 third-quarter rate.
Also watch forU.S. Healthcare Solutions revenue growth falls below 4.9% year over year in the next reported quarter.
Why it matters: Cencora raised its fiscal 2026 EPS floor to $17.90. Meeting or beating it would keep recent guidance increases on track.
Supportive ifFiscal 2026 adjusted diluted EPS is at least $17.90 in the final results.
Worry ifFiscal 2026 adjusted diluted EPS is below $17.90. Or, the company cuts its final outlook before it reports.
Why it matters: Cencora says the AON deal can add to adjusted EPS in its second year after closing. Results can test that claim.
Watch forAfter the deal closes, Cencora reports that AON added to adjusted diluted EPS in year two.
Also watch forCencora reports AON did not add to adjusted diluted EPS in the second year, or delays that goal.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$124 on $10,000 · ±1.2% | How much price usually moves either way. |
| Bad day | $247 loss on $10,000 · 2.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,245 loss on $10,000 · 32.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.